CSPC Pharma: Trustee Acquires 4.40 Million Shares for 2026 Restricted Share Award Scheme

Bulletin Express06-26

CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026.

The shares, acquired at an average price of HK$6.68, represent approximately 0.04% of CSPC’s issued share capital and involved a total consideration of about HK$29.41 million, excluding transaction costs. Following the transaction, the trustee now holds 46.18 million CSPC shares, equivalent to roughly 0.40% of the company’s outstanding shares.

Separately, BOCI-Prudential Trustee Limited—trustee of the 2018 Share Award Scheme—continues to hold 117.00 million shares under that program.

The board stated it will review and determine future share awards and any additional on-market purchases under both the 2018 and 2026 schemes at its discretion.

The announcement was issued in Hong Kong on 26 June 2026 and signed by Chairman Cai Dong Chen on behalf of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1136016388?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 19:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136016388","market":"us","top_or_hot":-1,"title":"CSPC Pharma: Trustee Acquires 4.40 Million Shares for 2026 Restricted Share Award Scheme","media":"Bulletin Express","content":"<p>CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026.</p>\n<p>The shares, acquired at an average price of HK$6.68, represent approximately 0.04% of CSPC’s issued share capital and involved a total consideration of about HK$29.41 million, excluding transaction costs. Following the transaction, the trustee now holds 46.18 million CSPC shares, equivalent to roughly 0.40% of the company’s outstanding shares.</p>\n<p>Separately, BOCI-Prudential Trustee Limited—trustee of the 2018 Share Award Scheme—continues to hold 117.00 million shares under that program.</p>\n<p>The board stated it will review and determine future share awards and any additional on-market purchases under both the 2018 and 2026 schemes at its discretion.</p>\n<p>The announcement was issued in Hong Kong on 26 June 2026 and signed by Chairman Cai Dong Chen on behalf of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSPC Pharma: Trustee Acquires 4.40 Million Shares for 2026 Restricted Share Award Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSPC Pharma: Trustee Acquires 4.40 Million Shares for 2026 Restricted Share Award Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-26 19:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026.</p>\n<p>The shares, acquired at an average price of HK$6.68, represent approximately 0.04% of CSPC’s issued share capital and involved a total consideration of about HK$29.41 million, excluding transaction costs. Following the transaction, the trustee now holds 46.18 million CSPC shares, equivalent to roughly 0.40% of the company’s outstanding shares.</p>\n<p>Separately, BOCI-Prudential Trustee Limited—trustee of the 2018 Share Award Scheme—continues to hold 117.00 million shares under that program.</p>\n<p>The board stated it will review and determine future share awards and any additional on-market purchases under both the 2018 and 2026 schemes at its discretion.</p>\n<p>The announcement was issued in Hong Kong on 26 June 2026 and signed by Chairman Cai Dong Chen on behalf of the board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1136016388","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136016388","pubTimestamp":1782473134,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026. The shares, acquired...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"石药集团：受讬人为2026年限制性股份奖励计划收购440万股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026.\nThe shares, acquired at an average price of HK$6.68, represent approximately 0.04% of CSPC’s issued share capital and involved a total consideration of about HK$29.41 million, excluding transaction costs. Following the transaction, the trustee now holds 46.18 million CSPC shares, equivalent to roughly 0.40% of the company’s outstanding shares.\nSeparately, BOCI-Prudential Trustee Limited—trustee of the 2018 Share Award Scheme—continues to hold 117.00 million shares under that program.\nThe board stated it will review and determine future share awards and any additional on-market purchases under both the 2018 and 2026 schemes at its discretion.\nThe announcement was issued in Hong Kong on 26 June 2026 and signed by Chairman Cai Dong Chen on behalf of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1136016388","isCrawlerRequest":true}